Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06270602

The ONCOCAMP Study

A Retrospective-prospective, Observational, Multicentric Study to Record Data From the ROC Platform and Monitor the ROC Performance

Status
Recruiting
Phase
Study type
Observational
Enrollment
15,000 (estimated)
Sponsor
National Cancer Institute, Naples · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study is a retrospective-prospective observational and multicentric study aiming to collect data relating to all patients included in the ROC platform. All ROC centers will be involved in the present study.

Detailed description

The ROC platform therefore represents a multicenter database and a growing source of data and information regarding cancer patients in the Campania region. The need for multicenter databases is supported by the results obtained with both retrospective and prospective studies. Many retrospective studies have led to changes in some of the available guidelines. Important advantages of this study include representativeness of the analyzed cohort to all patients with a specific cancer and a large sample size that provides sufficient statistical power to detect differences across different patient groups. The data extracted from the ROC have the potential to produce knowledge, to guide decision-making, and to manage more effectively the challenges of fighting cancer in our region. The Campania region counts more than 6 million people, and it is characterized by a worst oncological outcome compared to the average data of other Italian region: the ROC platform has the potential to analyze the effect of a public intervention in the field of oncology care. Therefore, the primary aim of this study is to create a retrospective-prospective registry of all cancer patients entering the ROC platform and in a GOM path describing the primary and secondary endpoints.

Conditions

Interventions

TypeNameDescription
OTHERData collection (retrospective)Collection of patient data entered in the ROC platform from the beginning activation of the platform (November 2018) until the date on which the study is approved by the local ethics committee
OTHERData collection (prospective)Collection of patient data entered in the ROC platform from the date in which the study is approved by the local ethical committee

Timeline

Start date
2023-07-14
Primary completion
2026-05-01
Completion
2026-07-01
First posted
2024-02-21
Last updated
2025-12-22

Locations

17 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06270602. Inclusion in this directory is not an endorsement.